Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/11/2025

Blood Pressure Management Guidelines

General Principles

  • The European Society of Cardiology recommends initiating antihypertensive treatment if systolic blood pressure is ≥160 mmHg or diastolic blood pressure is ≥100 mmHg, with a goal to reduce blood pressure to <140/90 mmHg in most patients, and to 120-129/<80 mmHg if well tolerated 1, 2
  • Initiate immediate antihypertensive drug therapy if sustained systolic blood pressure ≥160 mmHg or sustained diastolic blood pressure ≥100 mmHg, as recommended by the British Medical Journal 3, 2
  • For blood pressure 140-159/90-99 mmHg (Grade 1 hypertension), start drug treatment immediately in high-risk patients, according to the British Medical Journal and Hypertension 3, 2

Target Blood Pressure Goals

  • The European Society of Cardiology recommends a target blood pressure of <140/90 mmHg initially, then aim for 120-129/<80 mmHg if well tolerated 1, 2
  • For patients with diabetes, chronic renal disease, or established cardiovascular disease, the British Medical Journal recommends a target blood pressure of <130/80 mmHg 3, 1
  • For older patients (≥65 years), the European Society of Cardiology recommends a target systolic blood pressure of 130-139 mmHg 1

Medication Administration

  • Allow at least four weeks to observe the full response to medication adjustments, unless urgent blood pressure lowering is required, as recommended by the British Medical Journal 3, 4
  • Titrate drug doses according to manufacturers' instructions, except for thiazides/thiazide-like diuretics where the ideal dose is uncertain, according to the British Medical Journal 3, 4

Special Considerations

  • Most patients with hypertension will require at least two blood pressure lowering drugs to achieve recommended goals, according to the British Medical Journal 3
  • When adjusting medications, aim to reduce blood pressure by at least 20/10 mmHg, ideally to target levels, as recommended by Hypertension 2

Monitoring and Treatment

  • After medication adjustments, blood pressure should be rechecked within 4 weeks, according to Praxis Medical Insights 5
  • Target blood pressure control should be achieved within 3 months, as recommended by Hypertension and Praxis Medical Insights 2, 5
  • Use home blood pressure monitoring to confirm control, with target readings of <135/85 mmHg for home measurements, according to Praxis Medical Insights 5
  • First-line therapy includes ACE inhibitors/ARBs, calcium channel blockers, or thiazide/thiazide-like diuretics, as recommended by the European Heart Journal 1
  • If blood pressure remains uncontrolled on three-drug combination, add spironolactone or, if not tolerated, eplerenone, according to the European Heart Journal 1

Current Hypertension Management Guidelines

Treatment Initiation Thresholds

  • For high-risk patients with Stage 1 hypertension, immediate antihypertensive drug therapy is recommended if SBP 140-159/90-99 mmHg, according to the American College of Cardiology 6
  • For patients with SBP 130-139/80-89 mmHg, consider drug therapy if 10-year cardiovascular risk is ≥10%, as suggested by the American College of Cardiology 7

First-Line Pharmacological Treatment

  • For non-Black patients, the American Heart Association recommends starting with an ACE inhibitor/ARB, CCB, or thiazide-like diuretic 6
  • For Black patients, the American Heart Association recommends starting with a CCB or thiazide-like diuretic, or combination therapy 6

Combination Therapy

  • When using combination therapy, the American Heart Association suggests pairing medications from different classes, such as ACE inhibitor/ARB + CCB or thiazide-like diuretic 6
  • The American Heart Association advises against combining ACE inhibitors with ARBs due to increased adverse effects without additional benefit 6

Monitoring and Follow-Up

  • Target blood pressure control should be achieved within 3 months, according to the American Heart Association 6

Treatment of Resistant Hypertension

  • If spironolactone is not tolerated or contraindicated, the American Heart Association recommends considering amiloride, doxazosin, eplerenone, clonidine, or beta-blocker as alternative fourth-line therapy 6

Special Considerations

  • The International Society of Hypertension guidelines recommend reducing BP by at least 20/10 mmHg, ideally to target levels, for elderly patients 6